Cited by — Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial) | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial).
No admitted local citation edges point to this work yet.
